Preferred Label : neurofibrosarcoma;
MeSH definition : A malignant tumor that arises from small cutaneous nerves, is locally aggressive,
and has a potential for metastasis. Characteristic histopathologic features include
proliferating atypical spindle cells with slender wavy and pointed nuclei, hypocellular
areas, and areas featuring organized whorls of fibroblastic proliferation. The most
common primary sites are the extremities, retroperitoneum, and trunk. These tumors
tend to present in childhood, often in association with NEUROFIBROMATOSIS 1. (From
DeVita et al., Cancer: Principles & Practice of Oncology, 5th ed, p1662; Mayo Clin
Proc 1990 Feb;65(2):164-72);
MeSH synonym : neurogenic sarcoma; neurofibrosarcomas; sarcoma, neurogenic; neurogenic sarcomas; sarcomas, neurogenic;
MeSH hyponym : Neurilemmosarcoma; Neurilemmosarcomas; MPNST; Malignant Neurilemmoma; Malignant Neurilemmomas; Neurilemmoma, Malignant; Peripheral Nerve Sheath Tumors, Malignant; Malignant Neurilemoma; Malignant Neurilemomas; Neurilemoma, Malignant; Schwannoma, Malignant; Malignant Schwannoma; Malignant Schwannomas; Malignant Peripheral Nerve Sheath Tumor;
MeSH annotation : coordinate IM with precoordinated organ/neoplasm term (IM);
Wikipedia link : https://en.wikipedia.org/wiki/Malignant peripheral nerve sheath tumor;
Origin ID : D018319;
UMLS CUI : C0206729;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
HPO term
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
A malignant tumor that arises from small cutaneous nerves, is locally aggressive,
and has a potential for metastasis. Characteristic histopathologic features include
proliferating atypical spindle cells with slender wavy and pointed nuclei, hypocellular
areas, and areas featuring organized whorls of fibroblastic proliferation. The most
common primary sites are the extremities, retroperitoneum, and trunk. These tumors
tend to present in childhood, often in association with NEUROFIBROMATOSIS 1. (From
DeVita et al., Cancer: Principles & Practice of Oncology, 5th ed, p1662; Mayo Clin
Proc 1990 Feb;65(2):164-72)